Penn Medicine: Personalized Medicine Meets Thyroid Cancer: Drug Targeting BRAF Mutation Helps Patients
In the era of precision medicine, targeting the mutations driving cancer growth, rather than the tumor site itself, continues to be a successful approach for some patients.